The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain

被引:7
|
作者
Oestereich, Felix [1 ,2 ,3 ]
Yousefpour, Noosha [1 ]
Yang, Ethan [4 ]
Phenix, Jasmine [1 ,2 ]
Nezhad, Zari Saadati [4 ]
Nitu, Albert [1 ,2 ]
Coba, Antonio Vazquez [2 ,3 ]
Ribeiro-da-Silva, Alfredo [1 ]
Chaurand, Pierre [4 ]
Munter, Lisa Marie [1 ,2 ]
机构
[1] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada
[2] Bellini Life Sci Complex, Cell Informat Syst Grp, Montreal, PQ, Canada
[3] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada
[4] Univ Montreal, Dept Chem, Montreal, PQ, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Alzheimer's disease; CETP transgenic mice; LDL; 24S-hydroxycholesterol; mass spectrometry; microarray; brain lipids; complement system; C1Q; TREM2; IMAGING MASS-SPECTROMETRY; ALZHEIMERS-DISEASE RISK; CELLULAR CHOLESTEROL; DIETARY-CHOLESTEROL; IN-VITRO; LIPOPROTEIN; BARRIER; GENE; APOLIPOPROTEIN; HOMEOSTASIS;
D O I
10.1016/j.jlr.2022.100260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cholesteryl ester transfer protein (CETP) is a lipid transfer protein responsible for the exchange of cholesteryl esters and triglycerides between lipoproteins. Decreased CETP activity is associated with longevity, cardiovascular health, and maintenance of good cognitive performance. Interestingly, mice lack the CETP-encoding gene and have very low levels of LDL particles compared with humans. Currently, the molecular mechanisms induced because of CETP activity are not clear. To understand how CETP activity affects the brain, we utilized CETP transgenic (CETPtg) mice that show elevated LDL levels upon induction of CETP expression through a high-cholesterol diet. CETPtg mice on a high-cholesterol diet showed up to 22% higher cholesterol levels in the brain. Using a micro-array on mostly astrocyte-derived mRNA, we found that this cholesterol increase is likely not because of elevated de novo synthesis of cholesterol. However, cholesterol efflux is decreased in CETPtg mice along with an upregulation of the complement factor C1Q, which plays a role in neuronal cholesterol clearance. Our data suggest that CETP activity affects brain health through modulating cholesterol distribution and clearance. Therefore, we propose that CETPtg mice constitute a valuable research tool to investigate the impact of cholesterol metabolism on brain function.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] Effect of cholesteryl ester transfer protein (CETP) inhibitor peptide on plasma lipoprotein cholesterol in nonhuman primates
    Kushwaha, R
    McGill, HC
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 220 - 220
  • [12] Cholesterol ester transfer protein (CETP) in centenarians.
    Pascarelli, N
    Dormi, A
    Facchino, MR
    Campesato, M
    Mambelli, R
    Pignatelli, S
    Gaddi, A
    Sangiorgi, Z
    ATHEROSCLEROSIS, 1997, 135 : S17 - S17
  • [13] Synthesis of novel β-propanamides to inhibit cholesteryl ester transfer protein(CETP)
    Hong-Lei Xie
    Chun-Chi Liu
    Yi-Qun Li
    Chang-Lin Bai
    Chen-Zhou Hao
    Jing Guo
    Chang-Qun Luo
    Dong-Mei Zhao
    Mao-Sheng Cheng
    Chinese Chemical Letters, 2017, 28 (02) : 260 - 263
  • [14] Synthesis of novel β-propanamides to inhibit cholesteryl ester transfer protein (CETP)
    Xie, Hong-Lei
    Liu, Chun-Chi
    Li, Yi-Qun
    Bai, Chang-Lin
    Hao, Chen-Zhou
    Guo, Jing
    Luo, Chang-Qun
    Zhao, Dong-Mei
    Cheng, Mao-Sheng
    CHINESE CHEMICAL LETTERS, 2017, 28 (02) : 260 - 263
  • [15] VARIABILITY GENE EFFECT OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) GENES
    BERG, K
    KONDO, I
    DRAYNA, D
    LAWN, R
    CLINICAL GENETICS, 1989, 35 (06) : 437 - 445
  • [16] The cholesteryl ester transfer protein (CETP) locus and protection against atherosclerosis
    Berg, K
    GENES AND RESISTANCE TO DISEASE, 2000, : 51 - 65
  • [17] DNA POLYMORPHISM AT THE LOCUS FOR HUMAN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) IS ASSOCIATED WITH HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN LEVELS
    KONDO, I
    BERG, K
    DRAYNA, D
    LAWN, R
    CLINICAL GENETICS, 1989, 35 (01) : 49 - 56
  • [18] Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective
    Mohammadpour, Amir Hooshang
    Akhlaghi, Fatemeh
    CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 615 - 626
  • [19] Diphenylpyridylethanamine (DPPE) Derivatives as Cholesteryl Ester Transfer Protein (CETP) Inhibitors
    Harikrishnan, Lalgudi S.
    Finlay, Heather J.
    Qiao, Jennifer X.
    Kamau, Muthoni G.
    Jiang, Ji
    Wang, Tammy C.
    Li, James
    Cooper, Christopher B.
    Poss, Michael A.
    Adam, Leonard P.
    Taylor, David S.
    Chen, Alice Ye A.
    Yin, Xiaohong
    Sleph, Paul G.
    Yang, Richard Z.
    Sitkoff, Doree F.
    Galella, Michael A.
    Nirschl, David S.
    Van Kirk, Katy
    Miller, Arthur V.
    Huang, Christine S.
    Chang, Ming
    Chen, Xue-Qing
    Salvati, Mark E.
    Wexler, Ruth R.
    Lawrence, R. Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6162 - 6175
  • [20] Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
    Amand F. Schmidt
    Nicholas B. Hunt
    Maria Gordillo-Marañón
    Pimphen Charoen
    Fotios Drenos
    Mika Kivimaki
    Deborah A. Lawlor
    Claudia Giambartolomei
    Olia Papacosta
    Nishi Chaturvedi
    Joshua C. Bis
    Christopher J. O’Donnell
    Goya Wannamethee
    Andrew Wong
    Jackie F. Price
    Alun D. Hughes
    Tom R. Gaunt
    Nora Franceschini
    Dennis O. Mook-Kanamori
    Magdalena Zwierzyna
    Reecha Sofat
    Aroon D. Hingorani
    Chris Finan
    Nature Communications, 12